Business Context and Reporting Period
Company: Mustang Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 28, 2023 (Event Date: April 3, 2023)
Context: The filing reports a material modification to the rights of security holders via a 15-for-1 reverse stock split and amendments to the Company's Bylaws.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: A 15-for-1 reverse stock split was approved by stockholders and the Board of Directors. Every 15 pre-split shares were combined into one post-split share.
- Effective Date: The split became effective on April 3, 2023, with trading on a post-split basis commencing on April 4, 2023.
- Fractional Shares: No fractional shares were issued; holders received cash payments in lieu of fractional shares based on the closing price on the effective date.
- Equity Adjustments: Proportionate adjustments were made to the exercise prices and share counts for outstanding stock options, restricted stock units, and warrants. Share reserves under the 2016 Incentive Plan and 2019 Employee Stock Purchase Plan were reduced proportionately.
- Bylaw Amendment: The quorum requirement for stockholder meetings was changed from a majority of outstanding shares to a majority of the outstanding voting power.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of specific risks or contingencies beyond the standard disclosure that the description of the Amendment is qualified by reference to the full legal documents.
Investor Verification Checklist
- Verify the new CUSIP number for the post-split Common Stock (62818Q203).
- Confirm the adjusted number of shares held and the new exercise price for any outstanding options or warrants.
- Check for cash payments received in lieu of fractional shares if applicable.
- Review the Amended and Restated Bylaws (Exhibit 3.2) for the updated quorum requirements.